Josh Cohen

Founder at AMYLYX PHARMACEUTICALS, INC.

Net worth: 64 M $ as of 2026-06-29

34 year

9 connections

Technology Services

Consumer Services

Health Technology

Profile

Joshua B. Cohen is the founder of Amylyx Pharmaceuticals, Inc., founded in 2013, holding the title of Co-Chief Executive Officer & Director since 2014.
Mr. Cohen is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen currently holds the position of Director at Practice XYZ LLC.
Mr. Cohen completed undergraduate education at Brown University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AMYLYX PHARMACEUTICALS, INC. 3.24%	2026-04-09	3,583,548 ( 3.24% )	64 M $	2026-06-29

Josh Cohen active positions

Companies	Position	Start
AMYLYX PHARMACEUTICALS, INC.	Founder	2012-12-31
Practice XYZ LLC Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos	Director/Board Member	-

All active positions of Josh Cohen

Former positions of Josh Cohen

Companies	Position	End
Brown Biotechnology Investment Group	Founder	-

See the detail of Josh Cohen's experience

Training of Josh Cohen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Josh Cohen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Practice XYZ LLC Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos	Technology Services
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases	Health Technology
Brown Biotechnology Investment Group